AIM: Nogo extracellular peptide 1-40 (NEP1-40), a Nogo-66 antagonistic peptide, is one of the potential candidates for therapeutic intervention after central nervous system injury. This study is focused on the generation of TAT-NEP1-40 fusion protein and its transducible effects and biological activity. METHODS: TAT-NEP1-40 fusion protein was expressed in vitro. Transducible effects of TAT-NEP1-40 were analyzed by using immunofluorescence staining or Western blot in vitro and in vivo. The biological activity of TAT-NEP1-40 was assessed by its effects against oxygen and glucose deprivation (OGD)-induced PC12 cell damages. RESULTS: Our results showed that the TAT-NEP1-40 fusion protein was successfully expressed, purified, and refolded. Western blot analysis and immunofluorescence staining confirmed the delivery of TAT-NEP1-40 protein into PC12 cells and rat brains. OGD caused cell apoptosis or death, decreased cell viability, increased lactate dehydrogenase release in medium and the Bax/Bcl-2 ratio, all of which were prevented by the TAT-NEP1-40 fusion proteins when added exogenously to culture medium. In addition, TAT-NEP1-40 promoted neurite outgrowth of PC12 cells exposed to OGD. CONCLUSION: These results demonstrate that the TAT-NEP1-40 can be successfully generated and efficiently transduced into PC12 cells and rat brains. The TAT-NEP1-40 can protect PC12 cells against OGD and promote neurite outgrowth. This finding suggests that the transducible TAT-NEP1-40 fusion protein offers a possibility of the development of novel therapy for cerebral injuries via delivery of the biologically active TAT-NEP1-40 fusion protein into injured sites.
AIM: Nogo extracellular peptide 1-40 (NEP1-40), a Nogo-66 antagonistic peptide, is one of the potential candidates for therapeutic intervention after central nervous system injury. This study is focused on the generation of TAT-NEP1-40 fusion protein and its transducible effects and biological activity. METHODS:TAT-NEP1-40 fusion protein was expressed in vitro. Transducible effects of TAT-NEP1-40 were analyzed by using immunofluorescence staining or Western blot in vitro and in vivo. The biological activity of TAT-NEP1-40 was assessed by its effects against oxygen and glucose deprivation (OGD)-induced PC12 cell damages. RESULTS: Our results showed that the TAT-NEP1-40 fusion protein was successfully expressed, purified, and refolded. Western blot analysis and immunofluorescence staining confirmed the delivery of TAT-NEP1-40 protein into PC12 cells and rat brains. OGD caused cell apoptosis or death, decreased cell viability, increased lactate dehydrogenase release in medium and the Bax/Bcl-2 ratio, all of which were prevented by the TAT-NEP1-40 fusion proteins when added exogenously to culture medium. In addition, TAT-NEP1-40 promoted neurite outgrowth of PC12 cells exposed to OGD. CONCLUSION: These results demonstrate that the TAT-NEP1-40 can be successfully generated and efficiently transduced into PC12 cells and rat brains. The TAT-NEP1-40 can protect PC12 cells against OGD and promote neurite outgrowth. This finding suggests that the transducible TAT-NEP1-40 fusion protein offers a possibility of the development of novel therapy for cerebral injuries via delivery of the biologically active TAT-NEP1-40 fusion protein into injured sites.
Authors: Sha Mi; Xinhua Lee; Zhaohui Shao; Greg Thill; Benxiu Ji; Jane Relton; Melissa Levesque; Norm Allaire; Steve Perrin; Bryan Sands; Thomas Crowell; Richard L Cate; John M McCoy; R Blake Pepinsky Journal: Nat Neurosci Date: 2004-02-15 Impact factor: 24.884
Authors: Andrew B Seymour; Ellen M Andrews; Shih-Yen Tsai; Tiffanie M Markus; Melanie R Bollnow; Miranda M Brenneman; Timothy E O'Brien; Anthony J Castro; Martin E Schwab; Gwendolyn L Kartje Journal: J Cereb Blood Flow Metab Date: 2005-10 Impact factor: 6.200
Authors: David Koubi; Hao Jiang; Lijie Zhang; Wenxue Tang; Jarret Kuo; Alba I Rodriguez; Tangella Jackson Hunter; Michael D Seidman; George B Corcoran; Robert A Levine Journal: Neurochem Int Date: 2005-01 Impact factor: 3.921
Authors: Rachael T Richardson; Brianna Thompson; Simon Moulton; Carrie Newbold; May Ghee Lum; Adrian Cameron; Gordon Wallace; Robert Kapsa; Graeme Clark; Stephen O'Leary Journal: Biomaterials Date: 2006-09-27 Impact factor: 12.479
Authors: Dae Won Kim; Won Sik Eum; Sang Ho Jang; So Young Kim; Hee Soon Choi; Soo Hyun Choi; Jae Jin An; Sun Hwa Lee; Kil Soo Lee; Kyuhyung Han; Tae-Cheon Kang; Moo Ho Won; Jung Hoon Kang; Oh-Shin Kwon; Sung-Woo Cho; Tae Yoon Kim; Jinseu Park; Soo Young Choi Journal: Mol Cells Date: 2005-02-28 Impact factor: 5.034